Company profile: Ansh Labs
1.1 - Company Overview
Company description
- Provider of immunoassays for research and clinical diagnostics, custom immunoassay development (optimization and validation), monoclonal antibodies, and research reagents (antibodies, antigens, proteins), plus animal-specific assays for veterinary diagnostics. Focus areas include reproductive medicine, neurodegenerative disorders, and oncology.
Products and services
- Custom Immunoassay Development: Ansh Labs architects custom-engineered assays with optimization and validation, tailored to specific research needs for biomedical research and clinical diagnostics
- Immunoassays: Ansh Labs develops laboratory-grade novel immunoassays for research and clinical diagnostics, focusing on reproductive medicine, neurodegenerative disorders, oncology, and more across defined biomedical domains
- Monoclonal Antibodies: Ansh Labs supplies research-grade monoclonal antibodies for ELISA and Western Blot applications in biomedical research, compatible with common immunoassay workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ansh Labs
Mobilion Systems
HQ: United States
Website
- Description: Provider of high-resolution ion mobility mass spectrometry and targeted molecular analyses to identify and analyze challenging molecules that other instruments so far have failed to detect. Offers MOBIE for rapid, high-resolution separation and identification, plus targeted lipidomics, targeted proteomics, glycomics, metabolomics, and therapeutic oligonucleotide analysis for disease research, diagnostics, biomarker discovery, and therapeutic development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mobilion Systems company profile →
Pepscan
HQ: The Netherlands
Website
- Description: Provider of peptide R&D and production services, employing protein mimicry techniques and patented technologies. Offerings include peptide libraries, CLIPS technology, personalized neoantigen peptide pools, epitope mapping, and custom peptide synthesis with modifications, plus phage display and lead optimization at an end-to-end facility in Lelystad, the Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pepscan company profile →
Phenocell
HQ: France
Website
- Description: Provider of iPSC-derived cell models and R&D outsourcing for pharmaceutical, drug discovery, ophthalmology, dermatology, and dermo-cosmetic applications, including retinal pigment epithelial cells for retinal disorder research, a Dry AMD drug discovery platform, sebocytes for acne/hyperseborrhea, melanocytes for pigmentation, and high-throughput screening and custom bioassays with high genomic stability and reproducibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phenocell company profile →
Hemanext
HQ: United States
Website
- Description: Provider of blood processing, storage, and transfusion solutions. Offers Hemanext ONE, a blood container set for processing and storing red blood cells under reduced oxygen and carbon dioxide conditions to improve quality and extend shelf-life.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemanext company profile →
Nortis Bio
HQ: United States
Website
- Description: Provider of organ-on-a-chip systems and tissue-engineering techniques that create human micro-tissue environments within small, disposable microfluidic chips, enabling living models of human organs to accelerate discovery and help scientists better understand the causes of human diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nortis Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ansh Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ansh Labs
2.2 - Growth funds investing in similar companies to Ansh Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ansh Labs
4.2 - Public trading comparable groups for Ansh Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →